Existing drug can threat bloodless coVID – Jerusalem study

He thinks that the virus does this to be perpetuated in the host, and that if this procedure can be prevented, it will prevent the appearance of disorders in the organs, usually the lungs, that cause the virus to severely affect patients.

He claimed that the virus interfered with the body’s ability to break down fats and that phenofibrate revived this process. “The appeal of our test is that phenofibrate binds and activates the same DNA site that stops the virus, a component of our DNA that allows our cells to burn fats,” he said.

“A viral infection causes lung cells to accumulate fats and phenofibrate cells to burn them.”

Restarting the procedure is quick, he said, comparing it to “when the tub cover is removed.”

Nahmias stated that the main danger point of coronavirus is not caused by its infectious nature or the overall ability of the framework to get rid of the virus, but by the unique symptoms it causes. “Your framework can deal seamlessly with the virus, all we want to do is treat the symptoms,” he said.

“We want to give the virus time without falling into respiratory failure. And it’s through this that I think we can turn it into something much less serious, like the non-unusual cold.”

Leave a Comment

Your email address will not be published. Required fields are marked *